GERALDINE MICHEL: Open Payments
NPI 1447669643 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 10 payments from 8 companies in 2025. Trend: 2023 $162 · 2024 $242 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Recor Medical Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LEQVIO, JOURNAVX, JARDIANCE, Paradise Ultrasound Renal Denervation System, Kerendia, Rybelsus, FUROSCIX, NEXLETOL.
Industry payments across NY — which companies pay providers there.
